Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
61.7M
-
Number of holders
-
123
-
Total 13F shares, excl. options
-
44.7M
-
Shares change
-
-684K
-
Total reported value, excl. options
-
$864M
-
Value change
-
-$14.8M
-
Put/Call ratio
-
0.72
-
Number of buys
-
77
-
Number of sells
-
-50
-
Price
-
$19.33
Significant Holders of PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) as of Q4 2022
148 filings reported holding PLRX - PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q4 2022.
PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) has 123 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.7M shares
of 61.7M outstanding shares and own 72.44% of the company stock.
Largest 10 shareholders include FMR LLC (4.39M shares), Redmile Group, LLC (3.88M shares), CHI Advisors LLC (3.17M shares), Avidity Partners Management LP (2.24M shares), TRV GP IV, LLC (2.13M shares), VANGUARD GROUP INC (1.95M shares), TRV GP III, LLC (1.84M shares), JENNISON ASSOCIATES LLC (1.73M shares), Deep Track Capital, LP (1.73M shares), and Casdin Capital, LLC (1.68M shares).
This table shows the top 123 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.